SUMMARY Synovial fluid studies have been made on 43 patients with rheumatic disease. Lymphocytes separated by a 2-stage procedure were examined for the presence of activated large lymphoid cells or immunoblasts. Such immunoblasts were found in 19 of 21 patients with classical rheumatoid arthritis and 7 of 10 patients with seronegative polyarthritis, including patients with Still's disease, psoriatic arthritis, and ankylosing spondylitis. No immunoblasts were seen in synovial fluid from osteoarthrosis or in the inflammatory but nonimmune synovial fluid from crystal-induced arthritis. The presence of immunoblasts showed a correlation with the lymphocyte count in the synovial fluid but not with the total white cell count. Preliminary studies confirm the spontaneous metabolic activity of these cells by autoradiography and show them by scanning electron microscopy to have a villous surface membrane. Simultaneous peripheral blood studies showed a lower incidence of immunoblasts than in the synovial fluid. It is suggested that these cells originate in the synovial membrane. In view of the known migration characteristic of immunoblasts these cells may be important in the spread of immune arthritis as well as being markers of disease activity. Abnormalities 
Results
The 2-step method of purifying synovial fluid lymphocytes, utilising both Ficol-Hypaque and methyl cellulose carbonyl iron, gives clean preparations containing at least 98 % lymphocytes.
An activated large lymphoid cell, or immunoblast, stands out clearly from the other small lymphocytes (Fig. 1) . The percentage of immunoblasts in synovial fluids from the different patient groups is shown in Fig. 2 . In inflammatory polyarthritis the majority of synovial fluids contained immunoblasts in contrast to the absence of these cells in noninflammatory fluids in osteoarthrosis. Nineteen out of 21 patients with rheumatoid arthritis showed positive synovial fluid immunoblasts, as did 7 out of 10 patients with seronegative arthritis. The 3 patients with inflammatory nonimmune arthritis due to chondrocalcinosis all failed to show immunoblasts, though there were lymphoid cells in the synovial fluid. The total cell count together with the numbers of polymorphs and lymphocytes in the synovial fluid in the different groups is shown in Table 1 . The total cell count is, as expected, highest in patients with rheumatoid arthritis, who also have the highest frequency of immunoblasts. However, there is virtually no difference in the total cell count between the patients with seronegative polyarthritis, The relationship between the numbers of immunoblasts in the synovial and the concurrent peripheral blood studies are shown in Fig. 3 . In rheumatoid Immunoblasts in synovial fluid and blood in the rheumatic diseases 321 seem to be due to inflammation as such, since they were not found in the patients with crystal-induced inflammatory arthritis. The presence of immunoblasts in each patient correlates with the total number of lymphocytes in the synovial fluid. This has previously been shown to be high in a seronegative arthritis such as ankylosing spondylitis.'2 The number of immunoblasts does not correlate with the total synovial fluid white cell count, which is much higher in rheumatoid arthritis, but the majority of cells here are polymorphs. Previous studies had shown that peripheral blood immunoblasts correlated with other evidence of disease activity.' The number of rheumatoid patients showing peripheral blood immunoblasts was somewhat higher in the current study, in which the patients were selected because they had active disease with large synovial effusions. Even in this selected group with active disease the number of positive preparations was higher in the synovial fluid than in the peripheral blood, suggesting that the circulating immunoblasts might originate from within the joints. though direct studies of the migra- It is reasonable to assume that the origin of synovial fluid immunoblasts is from lymphoid tissue within the synovium itself. Indeed, blast cells, largely plasmablasts, have been described in electron microscopy studies of rheumatoid synovium.15
It is possible that those in the peripheral blood also come from this source.
The nature of the immunoblasts found in synovial fluid has not been investigated in detail, though they appear to be metabolically active cells, a finding that confirms the previous findings in peripheral blood.' The preliminary scanning EM pictures show a villous surface, which some authors believe is suggestive ofa B cell. '6 This accords with the immunofluorescent finding of some B cells among circulating immunoblasts (Delbarre et al.,1975) . However, the majority of circulating blast cells originate from T cells. '7 In RA synovial fluid B lymphocytes are often depressed, '8 19 and an increased number of null cells have been noted. The presence of activated immunoblasts, with temporary loss of surface markers, could contribute to the increased numbers of null cells, but further studies of these immunoblasts are required.
The current finding ofimmunoblasts in rheumatoid synovial fluid accords with previous evidence that synovial fluid lymphocytes are already precommitted. Increased spontaneous uptake of tritiated thymidine in the absence of stimulation has been noted20 together with poor responses to mitogens.2'
The significance of the immunoblasts in rheumatoid disease is 2-fold. At a simple level their mere presence is another laboratory marker for disease activity. At a more fundamental level it is known that immunoblasts have different circulation patterns and homing abilities from those of normal lymphoid cells. In the lamina propria of the small gut they appear to penetrate the endothelium of normal small intestine.22 By analogy immunoblasts may be able to penetrate the endothelium of noninflamed synovial joints. It has been suggested that a random population of uncommitted mononuclear cells has a specific ability to engage with a target antigen. 23 In the context of rheumatoid disease the immunoblasts may be cells capable of spreading synovial inflammation to noninflamed sites in other joints. 
